The following is a summary of “Racial disparities in patients with proliferative diabetic retinopathy treated with pars plana vitrectomy in an underserved population,” published in the April 2025 ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Diabetic retinopathy doesn’t show signs at an early stage and can lead to complete vision loss. The tool helps with timely ...